Concepedia

S Nagelberg

SN

Statistics

Publications

3

Citations

208

H-Index

3

Active since

1978

Affiliations

University of Oxford(Current)

S Nagelberg is an author at University of Oxford specializing in pharmacotherapy, chronic kidney disease, and chronic kidney disease management.

Publications per year

1978–2023

3

Publications

3

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

, , +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

, , +14

Medicaid-Funded Private Psychiatric Care in New York City

Barry B. Perlman, Arthur H. Schwartz, John C. Thornton et al. · New England Journal of Medicine · 1978 · 10 citations

, , +13

1–3 of 3